Hostname: page-component-69cd664f8f-ltgjb Total loading time: 0 Render date: 2025-03-12T06:11:33.862Z Has data issue: false hasContentIssue false
  • English
  • Français
Accepted manuscript

Esketamine nasal spray versus quetiapine XR in adults with treatment-resistant depression: a secondary analysis of the ESCAPE-TRD randomized clinical trial

Published online by Cambridge University Press:  17 January 2025

Roger S. McIntyre Open the ORCID record for Roger S. McIntyre [Opens in a new window] ,
Gregory Mattingly Open the ORCID record for Gregory Mattingly [Opens in a new window] ,
Yordan Godinov ,
Jozefine Buyze ,
Ibrahim Turkoz ,
Patricia Cabrera ,
Manish Patel ,
Larry Martinez ,
Mai Himedan  and
Oliver Lopena
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Original Research
Information
CNS Spectrums , Accepted manuscript , pp. 1 - 30
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)